The clinical effectiveness of EMDR second-step intervention for non-responders to CBT for Panic Disorder with or without Agoraphobia: an uncontrolled pilot study.
- Conditions
- Panic disorder
- Registration Number
- NL-OMON26887
- Lead Sponsor
- HSK, University of Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 15
1. a PD (with or without agoraphobia) as main classification according to DSM-5 based on the SCID-5-S (APA, 2017)
2. age above 18 years
3. sufficient mastery of Dutch to complete the questionnaires
4. less than 33.33 % symptom reduction after nine treatment sessions of CBT
5. stable medication use (type and dosage) for at least four weeks and willingness of both patient and treating physician/psychiatrist to keep it stable during the study period
6. use of anxiolytic medication is allowed, even reduction in intake this medication to engage better in treatment attending any other psychological treatment during the study is not allowed.
1. very severe depression (QIDS-C = 20)
2. acute suicidality
3. current Post Traumatic Stress Disorder (DSM-5)
4. severe alcohol or substance dependence (DSM-5)
5. lifetime psychotic disorder (DSM-5).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure will be severity of PD at follow up, measured with the Agoraphobic Cognitions Questionnaire (ACQ, Dutch version) and the Body Sensations Questionnaire (BSQ, Dutch version).
- Secondary Outcome Measures
Name Time Method The secondary outcome measure will be severity of symptomatology and stressors of psychopathology, measured with the Symptom Questionnaire-48 (SQ-48) and related aspects as impact of future events (IFES).